Latest Leadership News

Aurelia Metals delivered a sharply stronger FY26, with revenue, EBITDA and net profit rising as Federation entered commercial production and gold output exceeded revised guidance. The next test is whether the company can convert that momentum into higher throughput while managing costs, safety and execution risk.

Gateway Mining will elevate Richard Pugh to managing director and install Anthony McClure as chair after its November AGM, as the company prepares to intensify exploration at Yandal. The leadership reset comes with a $340,000 fixed package for Pugh and 15 million performance rights tied to share-price hurdles.

Locality Planning Energy has returned to statutory profit and sharply reduced borrowings, but its next test is converting a large contracted pipeline into active service points. The company has given no numerical FY2027 guidance and is operating under an interim leadership structure while it searches for a permanent CEO.

Biotron has appointed Glenn Gilbert as chief executive and executive director, bringing more than two decades of pharmaceutical, medical device and diagnostics experience to the company’s SedRx and antiviral programs. His package combines a $250,000 salary with up to 100 million performance-based options and $230,000 in milestone-linked cash bonuses.

LGI Limited (ASX:LGI) will elevate current CEO Jarryd Doran to Managing Director and CEO while reshaping its board and executive team from 1 December. The restructure includes 5.861 million proposed options for Doran and other executives, with shareholder approval required for the grants.

COSOL’s revenue fell 15.6% in FY26 and the ASX-listed asset management technology company swung to a $4.0 million statutory loss after goodwill impairments. Management is betting that leaner operations, new transport contracts and AI-led services can restore profitable growth, but the recovery still needs to show up in revenue.

Prescient Therapeutics has reached the first planned review threshold in its PTX-100 Phase 2a lymphoma study, while a completed A$6.0 million raise extends funding beyond the December milestone. The review will assess safety and efficacy, but is not a study completion or a new clinical result.

Maronan Metals has secured firm commitments for a $20 million placement to expand drilling and bring forward engineering, permitting and metallurgical work at its Queensland project. The raise is conditional on shareholder approval, with Kinterra Capital set to lift its interest to 22.99%.

Memphasys has reported record September-quarter invoiced revenue of A$211,000 as its Felix fertility device moves into more international markets. The commercial progress comes alongside A$3.5 million in funding, but the loan still requires shareholder approval for conversion into notes.

EBR Systems reported 40 WiSE commercial implants in Q3, down from 46 in Q2 and below its prior forecast, as leadership changes and a sales strategy reset disrupted activity. Higher Medicare reimbursement and progress at its new manufacturing facility offer potential offsets, but both remain dependent on execution and regulatory approval.

Abacus Group has begun an external search for a new managing director after Steven Sewell indicated he intends to retire by 9 July 2027, or earlier if a successor is appointed. The planned transition follows the completion of Storage King’s internalisation and comes with Sewell remaining in the role during the handover.

TZ Limited is still seeking funding after failing to complete its shortfall share placement, with $1.3 million in debt and vendor obligations due. The company says a management restructure, cost cuts and commercial opportunities could improve cash generation, but several forecasts remain conditional.